Lantus and Hepatitis e - a phase IV clinical study of FDA data

Summary:

Hepatitis e is reported as a side effect among people who take Lantus (insulin glargine recombinant), especially for people who are male, 40-49 old, also take Crestor, and have High blood pressure.

The phase IV clinical study analyzes which people have Hepatitis e when taking Lantus. It is created by eHealthMe based on reports of 190,478 people who have side effects when taking Lantus from the FDA, and is updated regularly.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

What is Hepatitis e?

Hepatitis e is found to be associated with 119 drugs and 181 conditions by eHealthMe. Check the latest studies of Hepatitis e.

On Jul, 11, 2026

190,478 people reported to have side effects when taking Lantus.
Among them, 16 people (0.01%) have Hepatitis e.

Among these 16 people:

What is the gender of people who have Hepatitis e when taking Lantus? *

female: 0.0 %
male: 100 %

What is the age of people who have Hepatitis e when taking Lantus? *

What are other drugs people take besides Lantus? *

Crestor: 3 people, 18.75%
Medrol: 2 people, 12.50%
Humalog: 2 people, 12.50%
Avelox: 2 people, 12.50%
Soliris: 2 people, 12.50%
Colecalciferol: 2 people, 12.50%
Ramipril: 2 people, 12.50%
Tramadol And Acetaminophen: 2 people, 12.50%
Bisoprolol Fumarate: 1 person, 6.25%
Entresto: 1 person, 6.25%

What are other side effects people have besides Hepatitis e? *

Ascites (accumulation of fluid in the abdominal cavity): 6 people, 37.50%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 6 people, 37.50%
Hepatic Fibrosis (scarring process that represents the liver's response to injury): 6 people, 37.50%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 5 people, 31.25%
Renal Impairment (severely reduced kidney function): 5 people, 31.25%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 25.00%
Hepatic Enzyme Increased: 3 people, 18.75%
Anaemia (lack of blood): 3 people, 18.75%
Disease Progression: 3 people, 18.75%
Alanine Aminotransferase Increased: 3 people, 18.75%

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 18.75%
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 2 people, 12.50%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 12.50%
Insulin-Requiring Type 2 Diabetes Mellitus: 2 people, 12.50%
High Blood Cholesterol: 2 people, 12.50%
Depression: 2 people, 12.50%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 12.50%
Pneumonia: 1 person, 6.25%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 6.25%
Immunodeficiency Disorders: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lantus and have Hepatitis e?

- Check whether Hepatitis e is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lantus:

Lantus (191,782 reports)

Hepatitis e treatments and more:

Hepatitis e (1,871 reports)

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis e:

Hepatitis e (119 drugs)

Browse all the conditions that are associated with Hepatitis e:

Hepatitis e (181 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine recombinant (the active ingredients of Lantus) and Lantus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.